Loading
AB
Apex Bioventures Acquisition Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by DEUTSCHE BANK AG\, was filed 23 Oct 2008.
Apex Bioventures Acquisition Corp: what insiders have been doing
Apex Bioventures Acquisition Corp is a listed company. Its insiders report their share dealings to SEC (Form 4). Apex Bioventures Acquisition Corp has had no insider filing for more than a year; the last one goes back to 27 April 2009.
The full history, which starts in 2008, counts 1 purchase against 3 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
4
Thresholds
n/a
Buy Volume
€467,780
1 ops. · all time
Sell Volume
€2M
3 ops. · all time
Last declaration on 27 April 2009
Declarations4 total
189,500 shares@ US$7.77APEX BIOVENTURES ACQUISITION CORPSEC:0000948046-09-000177:0
100,000 shares@ US$7.36APEX BIOVENTURES ACQUISITION CORPSEC:0000948046-08-000321:0
100,000 shares@ US$7.36APEX BIOVENTURES ACQUISITION CORPSEC:0000948046-08-000251:0
Canonical exit: 16 Jul 2008 (T+90)
100,000 shares@ US$7.35APEX BIOVENTURES ACQUISITION CORPSEC:0000948046-08-000162:0
4 of 4 declarations
About Apex Bioventures Acquisition Corp
Apex Bioventures Acquisition Corp is a special purpose acquisition company focused on the biotechnology sector. It aims to identify and merge with innovative companies in this field.
